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ABSTRACT
The emergence of antibiotic resistances has raised concerns in society about the widespread use of antibiotics, such as monensin, as growth enhancers in agriculture. Pressure to find
alternatives has increased since the European Union banned the use of ionophorous antibiotics.
Butyrate supplementation has been found to enhance growth in pre-weaned calves and it has
been recently suggested to enhance growth in post-weaned heifers. In a recent study by Rice in
2017, there was a quadratic (P=0.03) response for coccidia counts as sodium butyrate was
increased, with the lowest counts being at the intermediate doses. This suggested that butyrate
has the potential to decrease coccidian in post-weaned heifers. Monensin is also used as a
coccidiostat. While the objective of the study as a whole was to determine if sodium butyrate can
replace monensin in the prevention of coccidiosis and in enhancing growth and feed efficiency,
this report focuses only on the prevention of coccidiosis. At this time, only six of the forty
Holstein heifers entered the study. The design was a 2 X 2 factorial arrangement of treatments in
a randomized complete block design. Heifers were randomly assigned to 1 of 4 treatments: (1)
carrier (control; C); (2) 0.75 g SB/kg of body weight + carrier (SB); (3) 1.0 mg M/kg of body
weight + carrier (M); (4) (0.75 g SB/kg of body weight and 1.0 mg M/kg of body weight +
carrier (SB/M). Heifers entered the study and were trained to Calan doors from week 12 to 13
age of life. Treatment began on week 14 of life and continued for 12 weeks. Fecal samples were
taken from each calf weekly beginning in the covariate period for determination of coccidia.
(Measurements were also taken to evaluate the growth of post weaned calves and apparent total
tract nutrient digestibility). Oocyte counts were determined through the modified Wisconsin
sugar floatation method. Due to the small sample size a statistical analysis was unable to be
completed. However, the preliminary data suggested a negative trend in coccidian oocyte counts
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as treatment progressed. This indicates that both sodium butyrate and monensin have the ability
to decrease the shedding of coccidian oocytes, though the statistical significance is not known at
this time.
INTRODUCTION
IMPORTANCE OF DAIRY INDUSTRY
The dairy industry is extremely important to the economy of the globe. In 2011, there
was estimated to be about 260 million dairy cows globally (IDF, 2013). In 2010, global milk
production represented 8.9% of the value of all agricultural products (IDF, 2013). In some
countries, milk production accounts for over 20% of their total agricultural value (IDF, 2013).
The dairy industry employs up to 8% of the labor force in some countries (IDF, 2013). The dairy
industry is expected to steadily grow due to the high demand for quality animal protein as the
global population increases and economies emerge in developing countries (IDF, 2013). The
dairy industry is especially important to developing countries, and it is responsible for the
employment of approximately 750 million people on a small-scale dairy farms (IDF, 2013). In
the United States in 2012, milk production totaled at $35.5 billion, or 9% of United States
agricultural sales (USDA NASS, 2012). The USDA predicts that the export of dairy products
will increase from $4.6 billion in 2016 to $9.5 billion in 2026 (USDA, 2017). Quality dairy
products are in constant demand and this is unlikely to change. The dairy industry is a crucial
part of the global economy and the economy of the United States. It is imperative for research to
be conducted to make the industry more efficient and lucrative.
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DEVELOPMENT OF CALVES
Calves are born with underdevelopment digestive system which develops as the calf ages.
The food that the calf ingests in the beginning of its life has a huge impact on the development of
the calf’s digestive system. When a calf is born, it cannot digest feed in the same way that mature
cows digest feed. The rumen, reticulum, and omasum are not developed or functional. There is
an esophageal groove that allows the ingested liquid material to pass directly into the abomasum
(Hegland et. al., 1957). The abomasum, the gastric stomach compartment, is where early
digestion occurs in young calves, making young calves function like monogastric animals
(Heinrichs, 2005). Because of this, the diet of a calf in the first 8 weeks of its life is mainly
liquid, colostrum and milk or a milk replacer. Milk replacers are used instead of milk because
they are less costly than milk and do not significantly affect the growth rate of the calves (Jaster
et. al., 1989). However, a purely liquid diet does not promote optimal ruminal development.
In order to transition from a monogastric animal to a ruminant, the rumen must be stimulated
to develop. Certain feed requirements must be met to optimize ruminal development (Heinrichs,
2005). The epithelial layer of the rumen is responsible for the absorption if the nutrients digested
in the rumen. Papillae exist in the rumen to increase the surface area of the epithelial layer to
increase absorption. It has been found that early introduction of solid feed can stimulate the
rumen to develop more quickly (Heinrichs, 2005). The ingestion of dry feed and the introduction
of the microbial community result in the production of volatile fatty acids, which have been
found to stimulate the development of the rumen. Concentrates and diets with casein, starch,
cellulose, and minerals induce the development of the rumen better than a purely forage diet
(Heinrichs, 2005). Butyrate and propionate are two volatile fatty acids that have been shown to
enhance the development of the rumen (Heinrichs, 2005). These molecules are produced by
3

microbes in the rumen as a by-product of carbohydrate digestion. The types of microbes in the
rumen determine the amount of volatile fatty acids produced. Gram-negative bacteria increase
the amount of propionate while gram-positive bacteria increase the amounts of acetate and
butyrate.
Calves that have a more developed rumen at a younger age are more beneficial to farmers.
They grow more quickly and more efficiently and can mature at a younger age. This is important
to farmers because heifers consume resources without producing milk, meaning that farmers
must spend money on heifers without making money from them in milk sales. Consequently, the
sooner a heifer matures, the sooner she can be bred and become a source of income to the farmer,
and this decreases the cost of feeding heifers (Heinrichs et. al., 2013). Optimizing the
development, growth, and feed efficiency of calves and heifers can help farmers become more
lucrative.
COCCIODIOSIS
Coccidiosis is an economically significant disease caused by parasitic protozoans from
the genus Eimeria that infect the intestinal tract of many species, including sheep, chickens,
turkeys, and cattle. There are many species of Eimeria, and each species of Eimeria infects a
specific host species. The species that cause coccidiosis in cattle are primarily Eimeria bovis and
E. zurnii (Quigley et al., 1997). The parasites reproduce in the intestines and cause damage to the
intestinal tissue. The eggs produced are called oocytes. They are released in the feces and can
infect other cattle that ingest them.
Oocytes are essentially ubiquitous in the environment, so it is hard to prevent cattle
exposure to the parasite without a prevention plan. Young animals are most susceptible to
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coccidiosis because of their weak immune system, but adults in poor condition with weakened
immune systems can also develop clinical symptoms. Clinical symptoms include diarrhea,
bloody diarrhea, dehydration, weakness, and lack of appetite. Most cattle are infected
subclinically when they are calves and develop a strong immunity towards the parasite by
adulthood. Subclinical coccidiosis is also detrimental to the calf and the farmer. The parasites
destroy the lining of the intestine, causing inefficiency of nutrient absorption and decreased
appetite. This is detrimental to the growth and development of the calves and can lead to future
inefficiency in the mature animal. The economic loss due to coccidiosis in the United States has
been estimated to be $100 million (Taylor, 2016). In order to optimize the growth and feed
efficiency of calves and heifers, coccidiosis must be prevented.
MONENSIN: COCCIDIOSTAT AND GROWTH ENHANCER
Monensin is an ionophorous antibiotic which damages bacteria, and to a lesser extent
coccidian, by damaging the cell membrane so that the cell membrane can no longer effectively
maintain its proper ion concentrations (Hilton et. al., 1990). Ionophores have been found to have
coccidiostatic effects on dairy cattle, specifically in younger animals. In one experiment, calves
fed the ionophore lasalocid shed less oocyts than the control group (Quiglet, et. al., 1997).
Monensin has been shown to have coccidiostatic affects in cattle as well (Stickdale, 1981).
Monensin prevented clinical signs of coccidious in 10-week-old Holstein-Friesian calves
inoculated with oocytes (Fitzgerald and Mansfield, 1973). However, this antibiotic must be fed
daily due to the resilience of the protozoans. The only time monensin was found to affect the
parasites was after they reached the stage of sexual reproduction, because it is after this point that
they burst through the host cell and are able to come into contact with the drug (Melhorn et. al.,
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1983). Supplementing ionophores such as monensin at an early age has been shown to reduce
coccidian oocyst shedding.
Ionophores have the ability to change the microbial population in the rumen. As
previously stated, ionophores disrupt the ion gradient in the cell membrane of bacteria and
prevent the bacteria from maintaining adequate rates of cellular growth to sustain survival
(Russell and Strobel, 1989). However, ionophores do not affect all bacteria equally. Grampositive bacteria have a cell membrane that makes them more susceptible to damage from
ionophores (Callaway et al., 2003). With ionophorous treatment, the population of Gram-positive
bacteria is decreased, which provides more nutrients for Gram-negative bacteria to proliferate.
As previously mentioned, decreasing the population of Gram-positive bacteria will lower
concentrations of acetate and butyrate, and increasing the population of Gram-negative bacteria
will increase the concentration of propionate. These conditions increase feed efficiency in
heifers. Because of this, ionophores such as monensin have also been found to be growth
enhancers. Much research has been done to support monensin’s ability to increase growth and
feed efficiency. In one study, cattle fed monensin as a supplement to their diet gained weight
1.6% faster, ate 6.47% less, and required 7.5% less feed than the cows fed a normal diet
(Goodrich et. al., 1984). In another study, Heifers fed monensin at 200 and 600 mg/d levels
gained 0.09 kg/d more than animals on the control diet and had lower dry matter intakes, leading
to 12.6 and 13.4% greater efficiency in converting feed to body weight gain than control heifers
(Baile et al., 1982). The supplementation of ionophores in dairy cattle diets increases feed
efficiency. Monensin decreases feed intake while allowing cattle to maintain similar body weight
gains, making them more efficient.
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RISE OF ANTIBIOTIC RESISTANCES
Because of their effect as a growth enhancer, antibiotics including monensin are fed to
livestock on a large scale. It has been estimated that about 3.7million pounds of antibiotics are
used in cattle farms as grow enhancers annually in the United States (Mellon et. al., 2001). The
extensive use of antibiotics can lead to populations of resistance pathogens, and coccidian is no
exception. One study on broiler chickens showed that of the 10 Eimeria field isolates, 9 were
resistant to antibiotcs, and 6 of those were resistant to monensin specifically (Stephan et. al.,
1997). Another study showed that Eimeria meleagrimitis, parasite of turkeys, has the ability to
develop resistance to monensin as well (Jeffers and Bentley, 1980). However, bacterial
resistance to ionophores is not well understood. Even so, humans are not treated with
ionophores, so it is unlikely that ionophore-resisitant bacteria would affect people (Russell and
Houlihan, 2003). Nevertheless, the European Union has banned antibiotics including ionophores,
so there is a need to find growth enhancers that are not antibiotics.
BUTYRATE
Butyrate is a volatile fatty acid that is produced by microbial fermentation. Butyrate has
been found to have many functions in gut cells. Butyrate functions as a source of energy and as a
cellular mediator (Beford and Gong, 2017). Butyrate has been found to be able to alter gene
expression, induce cell differentiation, stimulate gut tissue development, induce immune
modulation, and control diarrhea in multiple species (Bedford and Gong, 2017). Butyrate can act
as a histone deactylase inhibitor. Butyrate blocks the actions of histone deactylase molecules,
resulting in the activation of silent genes (Marks et. al., 2000). Butyrate has been found to have
anti-inflammatory properties. In humans, one of the most studied mechanisms is the inhibition of
nuclear factor kappa B. This controls the expression of genes encoding pro-inflammatory
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cytokines, inflammation-inducing enzymes, growth factors, heat shock proteins, and immune
receptors (Vinolo et al., 2011). In vitro, sodium butyrate induced expression of host defense
peptides in chicken cell types including macrophages, monocytes, bone marrow cells, jejunal
cells, and cecal cells (Sunkara et.al., 2011). Butyrate has been found to have antimicrobial
properties in chickens, in pigs, and in humans. Butyrate has been shown to reduce and prevent
the colonization of Salmonella in broiler chickens (Fernandez-Rubio et. al., 2009). The reported
beneficial effects of butyrate supplementation (antimicrobial and anti-inflammatory activities,
enhancement of growth performance and gut tissue development, modulation of immune
response and intestinal microbiota) in humans, poultry, and pigs suggest that butyrate could be a
potential substitute for in-feed antibiotics (Bedford and Gong, 2017).
Butyrate is also an importance source of energy in cows as well as cellular modulator.
Supplementing dietary butyrate to newborn calves has been shown to cause the acceleration of
gastrointestinal tract (GIT) development, including the rumen, abomasum, small intestine, and
pancreas (Gorka et. al., 2011a). Butyrate can also modulate GIT secretion of peptides and
hormones (Guilloteau et. al., 2009b). In calves, administration of butyrate directly into the rumen
stimulated proliferation of epithelial cells and reduced epithelial cell apoptosis, resulting in
longer papillae (Mentschel et. al., 2001). When butyrate is supplemented in dry feed, it affects
the rumen. When butyrate is supplemented in liquid feed, it affects the abomasum and small
intestine. Consequently, butyrate should be added to both dry and liquid feed in calves to
stimulate development of the entire GIT (Gorka et. al., 2011a). Butyrate has been shown to
improve growth, but the exact mechanism has not been determined in detail in ruminants (Gorka
et. al., 2018). When butyrate was supplemented to calves in milk replacer, the calves has reduced
incidences of scours (Gorka et. al., 2011a).
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Most of the research on butyrate has focused on its effect on pre-weaned calves. In work
completed at the University of New Hampshire by Rice in 2017, different concentrations of
sodium butyrate were supplemented in the heifer’s diet (0g/kg of body weight, 0.25g/kg body
weight, 0.5g/kg of body weight, and 0.75g/kg of body weight). This was believed to be the first
experiment to evaluate the supplementation of sodium butyrate to post-weaned heifers. Results
of this research indicated that as sodium butyrate increased in the diet, dry matter intake was
unchanged. However, overall weight gain and average daily gain increased with an increase in
sodium butyrate. While not statistically significant, the observations suggested that as sodium
butyrate increased in the diet, there was improvement in feed efficiency with no negative effects
seen in the heifers. There was also a significant quadratic response in coccidian counts as the
amount of sodium butyrate increased. The results indicated that at a dosage of 0.25g SB/kg of
body weight was most effective in reducing the shedding of coccidian oocytes.
Because of the effects of sodium butyrate (SB) on weight gain, average daily gain, feed
efficiency, final weight and coccidian counts, it appears that sodium butyrate is acting in the gut
producing responses similar to those when monensin (M) is fed to cattle. With the effort to
decrease the use of antibiotics across the globe, sodium butyrate is a potential replacement for
ionophores. The aim of this study is to see if SB is an effective replacement for monensin for
aiding in prevention of coccidiosis and nutrient absorption through altering the rumen
environment. While the focus of the study as a whole (completed by Tess Stahl) is to evaluate
the growth of post-weaned calves and apparent total tract nutrient digestibility of diets containing
no treatment, 0.75 g SB/kg of body weight, 1 mg of M/kg of body weight, or the combination
(0.75g SB/kg of bodyweight and 1mg M/kg of body weight), this report is focused specifically
on evaluating the coccidian counts in the post weaned calves feed diets containing 0, 0.75 g/kg
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SB, 1 mg/kg monensin or the combination. It is hypothesized that sodium butyrate will be able to
replace monensin and the two treatments will yield similar coccidian oocyte counts.
METHODS
Forty Holstein heifers will be included in this study. At this point in the study, only six of
the forty calves entered the study. The design was a 2 X 2 factorial arrangement of treatments in
a randomized complete block design. Heifers were randomly assigned to 1 of 4 treatments: (1)
carrier (control; C); (2) 0.75 g SB/kg of body weight + carrier (SB); (3) 1.0 mg M/kg of body
weight + carrier (M); (4) (0.75 g SB/kg of body weight and 1.0 mg M/kg of body weight +
carrier (SB/M). The carrier used was soybean meal. Treatments were adjusted weekly according
to body weight. Heifers entered the study and were trained to Calan doors from week 12 to 13
age of life. Each heifer was assigned a specific door and assisted with opening the door during
this week until they were able to enter and exit on their own. Treatment began during week 14 of
life and the heifers remained on the study for 12 weeks.
Pre-trial measurements (body weight, heart girth, paunch girth, body length, DMI, blood
concentrations of β-hydroxybutyrate (BHB), glucose, fecal oocyte count) served as covariates.
Daily dry matter intake was measured and calves were fed a haylage based diet at the same time
daily. Total mixed ration samples were taken weekly and composited monthly for nutrient
analyses. Orts samples were taken daily and composited by month for each calf. Feed
ingredient samples were taken monthly for nutrient analyses. Blood samples for BHB and
glucose analyses, body weight and skeletal measurements (heart girth, paunch girth, body
length), and fecal samples for oocyte determination were taken once every Tuesday at 8:00am.
Body length, heart girth, and paunch girth were measured with weight tape. Body weight was
determined with a platform scale. Blood samples were taken from the jugular vein using a 2010

gauge needle before the administration of treatments. Samples were collected in 2 10-mL
vacutainer tubes, 1 containing anticoagulant EDTA and 1 without anticoagulant. Concentrations
of BHB were obtained utilizing a hand-held electronic blood glucose and ketone monitoring
system. Apparent total tract digestibility was determined twice during the experiment, once
during the third week and once during the ninth week. Chromium oxide (4 g/d) was dosed twice
daily (12 h intervals) for 7 d, and fecal samples taken over the last three days of the period to
mimic a 24 h period.
The coccidian oocyte counts were determined using the Modified Wisconsin sugar float
test. Sheather’s solution was made by dissolving 90.8 grams of sugar into 71.0 milliliters of hot
water. The solution was covered and cooled to 38°F before use. To complete the sugar float test,
3 grams of fecal matter was mixed thoroughly in 10mL of Sheather’s solution. The mixture was
strained into a 15mL test tube and centrifuged at 1200rpm for 5minutes at 4°C. After
centrifugation, the test tubes were slightly over-filled with Sheather’s solution, until a meniscus
formed at the top of the tube. A coverslip was then placed on the meniscus. After 10 minutes, the
coverslip was placed a slide and viewed under light microscopy. Oocytes were counted at 10x
over the entire area of the coverslip.
At this stage of the study, significant statistical analysis was not possible. The sample size
was too small due to time restrictions to accurately run a statistical analysis. However, the
preliminary data was analyzed. The oocytes counts were converted to oocytes per kilogram of
feces. The oocytes per individual heifer were plotted in scatterplots to observe trends. The data
from each heifer was plotted in two charts. The first was a simple scatterplot with connected
points to visualize the progression of the oocyte counts per week. The second was a scatterplot
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with a linear regression to determine if there was a relationship between the number of oocytes
and the progression of treatment throughout the weeks of the experiment.
RESULTS
The individual observations of oocyte counts in eggs per kilogram of feces is summarized
in Table 1. The observations vary among individual heifers, as seen by the standard deviations in
Table 2. The total and average oocytes counts for each treatment is summarized in Table 2. In
the preliminary data, the combination of treatments SB/M yielded the highest average oocyte
count at 5309.091 eggs/kg. Monensin yielded the second highest oocyte count at 2925.556
eggs/kg. Sodium butyrate yielded 1512.308 eggs/kg. The lowest oocyte count occurred in the
control treatment, with 1332.857 eggs/kg.
Table 1: Individual oocyte counts for each heifer
962
SB

Week
0
1
2
3
4
5
6
7
8
9

0
0
0
0
1000
0
0
0
0
0

965
966
963 M 964 C
SB/M
SB/M
967 SB
0
2000
3000
14330
15330
0
2000
5530
0
2330
7000
1670
31330
2330
1000
19330
2000
500
0
0
1000
1250
330
0
330
0
0
330
0
0
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Table 2: Total observations, oocytes counts, average oocyte counts and standard deviations per
treatment
SB
Total observations
Total oocyte count (eggs/kg)
Average oocyte count (eggs/kg)
Standard deviation (eggs/kg)

M

SB/M

Control

13
9
11
7
19660
26330
58400
9330
1512.308 2925.556 5309.091 1332.857
4210.165 6572.852 9600.136 771.4859

The trend in oocyte count over weeks of treatment of sodium butyrate for 962 is
summarized in Figures 1 and 2. The oocyte count in this heifer remained low and stable. A
negative relationship was observed. The equation for the linear regression is y = -6.0606x +
127.27 with an R-squared of 0.0536 (Figure 2). The trend for oocyte count during the course of
treatment of monensin for 963 in summarized in Figures 3 and 4. The oocyte count in this heifer
had a peak during week 3 of treatment, but dropped by week 4 and remained stable for the rest
for the treatment (Figure 3). The negative relationship was observed. The equation for the linear
regression is y = -555.5x + 5147.6 with an R- squared of 0.0536 (Figure 4). The trend for oocyte
count during the control treatment for 964 is summarized in Figures 5 and 6. The oocyte count in
this heifer remained stable, remaining between 1000 and 2000 eggs/kg, until dropping slightly in
the last two weeks (Figure 5). The negative relationship was observed. The equation for the
linear regression is y = -322.14x + 2299.3 with an R-squared of 0.8137 (Figure 6). The first
heifer on combination treatment (965) saw a peak in oocyte count at week 2 (Figure 7). After
week 2, the oocyte count dropped down. There was a negative trend with a linear regression
equation of y = -1676.3x + 11126 with an R- squared of 0.067 (Figure 8). 966, the second heifer
treated with combination began the study with a high oocyte count and it dropped over the
course of the treatment (Figure 9). The linear regression was negative with an equation of y = -
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2800x + 8998 and an R-squared of 0.5119 (Figure 10). 967, the second heifer treated with
sodium butyrate, had the highest counts in the covariate week and the counts dropped in the
following weeks (Figure 11). The linear regression was negative with an equation of y = -7165x

962 - Sodium Butyrate
35000
30000
25000
20000
15000
10000
5000
0
0

1

2

3

4

5

6

7

8

9

10

Oocyte count (eggs per kg)

Oocyte count (eggs per kg)

+ 13385 and an R-squared of 0.819 (Figure 12).

962 - Sodium Butyrate
35000
30000
25000
20000
15000
10000
5000
0

y = -6.0606x + 127.27
R² = 0.0034
0

1

2

963 - Monensin
35000
30000
25000
20000
15000
10000
5000
0
1

2

3

4

5

6

4

5

6

7

8

9

10

Figure 2: Linear regression of the number of
oocytes in 962 as the treatment of sodium
butyrate progressed

Oocytes count (eggs per kg)

Oocytes count (eggs per kg)

Figure 1: Line chart showing the
progression of oocyte counts throughout
the treatment of sodium butyrate in heifer
962

0

3

Week of Treatment

Week of Treatment

7

8

9

30000
25000
20000
15000
10000
y = -555.5x + 5147.6
R² = 0.0536

5000
0
0

Week of Treatment

Figure 3: Line chart showing the
progression of oocyte counts throughout
the treatment of monensin in heifer 963

963 - Monensin
35000

1

2

3

4

5

6

7

8

9

Week of Treatment

Figure 4: Linear regression of the number of
oocytes in 963 as the treatment of monensin
progressed
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964 - Control
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8

9

964 - Control
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y = -322.14x + 2299.3
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1

2
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6
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Week of Treatment

8
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Figure 7: Line chart showing the
progression of oocyte counts throughout
the combination treatment in heifer 965
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965 - SB/M Combination

965 - SB/M Combination

1
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Figure 6: Linear regression of the number of
oocytes in 964 as the control treatment
progressed

Figure 5: Line chart showing the progression
of oocyte counts throughout the control in
heifer 964
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Figure 8: Linear regression of the number of
oocytes in 965 as combination treatment
progressed
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966 - SB/M Combination
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966 - SB/M Combination
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25000
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15000
10000
5000
0
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y = -2800x + 8998
R² = 0.5119
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2

3
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Figure 9: Line chart showing the
progression of oocyte counts throughout
the combination treatment in heifer 966
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967 - Sodium Butyrate
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Figure 10: Linear regression of the number of
oocytes in 966 as the combination treatment
progressed

967 - Sodium Butyrate

0

4
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Figure 11: Line chart showing the
progression of oocyte counts throughout
the treatment of sodium butyrate in heifer
967
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Figure 12: Linear regression of the number
of oocytes in 967 as the treatment of
sodium butyrate progressed
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DISCUSSION
The preliminary results suggest that both monensin and sodium butyrate are associated
with a decrease in coccidian counts. The slopes of all the treatments were negative, indicating
that as the heifers were being treated, the number of coccidian decreased. While the control
group also had a negative slope, the control group had the slope of the least magnitude, with the
exception of 962. 962 had extremely low coccidian counts, so it is very possible that in the final
analysis this heifer will be considered an outlier. 963 experienced a spike in oocytes at 3 weeks
of treatment with monensin and 965 experienced a peak at two weeks into treatment with the
combination of SB/M. This could be due to the life cycle of the Eimeria species. The life cycle is
21 days, so when an animal is infected, the oocytes will not show in the feces until about 3
weeks later. This means that when 963 and 965 experienced peak coccidian counts at 2 and 3
weeks, they were showing the symptoms of an infection that likely began before the treatment
began. As previously mentioned, monensin affects only the sexually mature protozoan.
Depending on the stage of the life cycle of the parasites, monensin may not have been effective
immediately.
Though preliminary, these data suggest that sodium butyrate could possibly replace
monensin in the prevention of coccidiosis. The mechanism through which sodium butyrate could
prevent coccidiosis in heifers is not definitively known. That being mentioned, it is possible that
butyrate causes enough proliferation of the epithelial cells that the protozoan are not able to
establish an infection in the epithelial cells before new epithelial cells take their place. It is also
possible that butyrate induces the production of host defense peptides to aid the cells in the
defense against an infection, as has been seen in other species like chickens.
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While the preliminary data suggest that sodium butyrate has potential to be a replacement
for monensin in the prevention of coccidiosis, there are details that could have affected the
results. In this study, the concentration of sodium butyrate that was used was based off of the
concentration in a previous study that yielded the best growth and feed efficiency, which was
0.75g SB/kg. It was not based off of the best concentration for the prevention of coccidiosis,
which was 0.25g SB/kg. It is likely that the results would be different if a different concentration
of sodium butyrate was used. This needs future research to be determined.
The source of butyrate, sodium butyrate, could have affected the results as well. Sodium
butyrate has a high availability and a modest price, but there are other sources of dietary
butyrate. Sodium butyrate dissolves easily in water (Mallo et al., 2012). As a result, dietary
sodium butyrate rapidly dissociates in the stomach and it probably mostly absorbed there, instead
of the small intestine or colon (Guilloteau et al., 2009b). When sodium butyrate is used, it is
unsure how much, if any, of the butyrate is being delivered to the small intestine. Calcium
butyrate is much less soluble in water solutions compared with sodium butyrate and could
potentially deliver more butyrate to the small intestine (Mallo et al., 2012). Another way butyrate
could be protected to change the site of absorption is in embedded in a lipid matrix of a vegetable
saturated fat such as palm oil; however, the exact composition of the lipid matrix is rarely
reported (Moquet et al., 2016). When protected in the lipid matrix, butyrate is only partially
released in the stomach and most of active substance is released in the small intestine (Piva et al.,
2007; Guilloteau et al., 2009a). This could very easily change the results because more butyrate
would be acting directly on the epithelium of the small intestine, which is the site of coccidian
infection.
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There are many factors that can affect the incidence of coccidian infection in heifers, and
ultimately skew the results. Individual differences in immunity strength could have affected the
coccidian counts. Any type of stress can result in an infection because stress depresses immunity.
There are many things that could have caused stress in the heifers. The process of moving from
smaller hutches to the bigger pens could have caused stress. Stress from the enforcement of
social hierarchy could have depressed the immunities of younger and smaller heifers. Fluctuating
weather and over-crowding could have caused stress. Other illnesses such as ringworm and
scours (not caused from coccidia) were observed in the heifers and they could have made heifers
more susceptible to an infection. All of these factors could have had an effect on the results.
There is much potential for future research regarding butyrate. The mechanism of how
butyrate effects the tissue on a molecular level in the heifers is not understood and needs to be
studied. It is also unclear exactly where butyrate directly affects the tissue depending on the
source and protection of butyrate. Different sources of butyrate could potentially have different
affects in cattle of all ages. It also unknown exactly how butyrate affects the microbiota in the
entirety of the GIT. The most effective dose of butyrate, source of butyrate, administration of
butyrate, and time to be administered in the cow’s life are all still to be determined. The longterm effects of butyrate supplementation from newborn to adulthood should also be studied.
Despite this, current research has shown that butyrate has great potential to be a replacement for
ionophores.
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